Ligandal
Enterprise Systems (Healthcare)Website
Developer of nanomedicine therapies designed to offer gene editing tools with non-viral nano-carriers to treat gene-related diseases. The company's therapies include peptide-based technologies for gen...
Valuation
$0
Share Price
N/A
Total Raised
$9.2M
Last Round
Seed Round
Sep 2018
Latest Funding Round
Seed Round
Sep 7, 2018
$4M
raised
Investors
+42 other investors